[研究报告] 对乙酰氨基酚市场预计将从 2022 年的 99.9329 亿美元增长到 2030 年的 142.5444 亿美元;预计该市场在 2022-2030 年期间的复合年增长率为 4.5%。
市场洞察和分析师观点:
扑热息痛是一种非处方非阿片类止痛药和退热药。它被广泛用于治疗发烧和轻度至中度疼痛。扑热息痛以各种形式出售,包括片剂、胶囊、可溶性粉末和液体。扑热息痛的一些常见品牌包括 Calpol、Disprol、Hedex、Medinol 和 Panadol。疼痛和发烧状况的高发性以及消费者对非处方 (OTC) 药物的偏好不断增加是推动扑热息痛市场增长的关键因素。然而,扑热息痛过量的影响阻碍了市场的发展。
增长动力和限制因素:
疼痛相关疾病和发烧的发病率不断上升,推动了对乙酰氨基酚市场规模的增长。对乙酰氨基酚通常用于缓解轻度至中度疼痛和控制发烧,具有显著的疗效。根据美国食品药品监督管理局 (FDA) 的数据,对乙酰氨基酚 (扑热息痛) 是治疗发烧和疼痛的首选药物。传染病的高发性刺激了对扑热息痛的需求。根据世界卫生组织 (WHO) 的数据,季节性流感每年在全球造成 290,000-650,000 人死亡。同样,根据 CDC 的估计,2010-2022 年期间,美国流感病例从 940 万增加到 4100 万。扑热息痛与其他药物结合使用,可治疗咳嗽、感冒、流感和过敏等疾病。同样,含有扑热息痛和其他活性成分组合的药物被广泛用于治疗剧烈疼痛。例如,它与尼美舒利或双氯芬酸的组合可用于治疗发烧、肌肉痛、牙痛、头痛、强直性脊柱炎、轻度偏头痛、类风湿性关节炎、骨关节炎和痛经等病症。同样,对乙酰氨基酚与醋氯芬酸和舍雷替肽酶的组合可用于减轻肿胀和缓解肌肉痛、术后痛、关节痛和其他病症的疼痛。因此,随着此类健康问题的全球流行率不断上升,对乙酰氨基酚作为一种广受信赖且易于获得的止痛选择的需求大大增加了其需求。
然而,潜在的副作用对扑热息痛市场有重大影响。扑热息痛,又称乙酰氨基酚,用于缓解疼痛和发烧。尽管扑热息痛被广泛使用,并且按指示使用时被认为是一般安全的,但其使用也存在一些特定的副作用和担忧。扑热息痛最显著的副作用之一是过量服用或使用不当会导致肝损伤的风险。这是一个主要问题,可能会影响消费者对产品的信心,从而导致使用量减少。根据 2022 年发表在 ScienceDirect Journal 上的一项研究“尼日利亚与美国使用的扑热息痛剂量方案的潜在有害影响”,扑热息痛是美国和欧洲已知的急性肝衰竭原因之一。同一消息来源报道称,扑热息痛中毒可能是尼日利亚肝脏疾病的原因。因此,扑热息痛的副作用阻碍了扑热息痛市场的增长。
定制此报告以满足您的需求
您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣
- 获取此报告的关键市场趋势。这个免费样品将包括数据分析,从市场趋势到估计和预测。
报告细分和范围:
“对乙酰氨基酚市场分析”是通过考虑以下部分进行的:剂型、适应症、给药途径和分销渠道。 根据剂型,对乙酰氨基酚市场分为片剂、胶囊剂和其他剂型。根据适应症,市场分为发烧、感冒咳嗽、轻度和中度疼痛和其他。根据给药途径,市场分为肠内和肠外给药。在分销渠道方面,市场细分为医院药房、零售药房和网上药房。从地理上讲,市场细分为北美(美国、加拿大和墨西哥)、欧洲(德国、法国、意大利、英国、俄罗斯和欧洲其他地区)、亚太地区(澳大利亚、中国、日本、印度、韩国和亚太地区其他地区)、中东和非洲(南非、沙特阿拉伯、阿联酋和中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)。
节段分析:
根据剂型,对乙酰氨基酚市场分为片剂、胶囊剂和其他剂型。片剂在 2022 年占据了最大的市场份额,预计在 2022-2030 年期间的复合年增长率最高。
根据适应症,市场分为发烧、感冒咳嗽、轻度和中度疼痛等。发烧部分在 2022 年占据了最大的市场份额。预计轻度和中度部分将在 2022 年至 2030 年期间实现最高复合年增长率。
根据给药途径,对乙酰氨基酚市场分为肠内和肠外给药。2022 年,肠内给药占据了更大的市场份额,预计在 2022-2030 年期间将实现更高的复合年增长率。
根据分销渠道,扑热息痛市场分为医院药房、零售药房和在线药房。2022 年,零售药房占据最大市场份额,预计在 2022-2030 年期间复合年增长率最高。
区域分析:
对乙酰氨基酚市场报告的范围涉及北美洲、欧洲、亚太地区、南美洲和中美洲以及中东和非洲。2022 年,北美占据了全球对乙酰氨基酚最大的市场份额。医疗基础设施的发展、传染病的流行以及美国各地医疗服务支出的增加是该地区市场增长的推动因素。根据美国卫生与公众服务部的数据,每年有 3-11% 的美国人口感染并出现流感症状。根据 2020 年 7 月发布的全球疾病负担研究的结果,美国的非传染性和传染性疾病负担沉重且不断增加。根据约翰霍普金斯大学的数据,过去二十年,美国 SARS、莱姆病、登革热、西尼罗河病毒和寨卡病毒感染等疾病的病例迅速增加。同一消息来源证实,疟疾、结核病、霍乱、百日咳、流感、肺炎球菌病和淋病等重新出现的疾病的发病率有所增加。扑热息痛和其他用于抑制发烧和类似症状的药物是治疗传染病的处方药。因此,传染病发病率的上升增加了美国对扑热息痛的需求,促进了扑热息痛市场份额的扩大。
对乙酰氨基酚市场区域洞察
Insight Partners 的分析师已详细解释了预测期内影响扑热息痛市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的扑热息痛市场细分和地理位置。
- 获取对乙酰氨基酚市场的区域特定数据
对乙酰氨基酚市场报告范围
报告属性 | 细节 |
---|---|
2022 年市场规模 | 99.9329亿美元 |
2030 年的市场规模 | 142.5444亿美元 |
全球复合年增长率(2022 - 2030 年) | 4.5% |
史料 | 2020-2022 |
预测期 | 2022-2030 |
涵盖的领域 | 按剂型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
对乙酰氨基酚市场参与者密度:了解其对业务动态的影响
由于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素,最终用户需求不断增加,推动了对乙酰氨基酚市场快速增长。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者需求,并利用新兴趋势,从而进一步推动市场增长。
市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。
在对乙酰氨基酚市场运营的主要公司有:
- 马林克罗特制药公司
- 葛兰素史克公司
- 梯瓦制药工业有限公司
- 太阳制药公司
- 赛诺菲
免责声明:上面列出的公司没有按照任何特定顺序排列。
- 获取对乙酰氨基酚市场顶级关键参与者概述
行业发展和未来机遇:
扑热息痛市场预测可以帮助该市场的利益相关者制定增长战略。以下列出了全球扑热息痛市场主要参与者采取的一些举措:
- 2023 年 10 月,爱尔兰精神健康和老年人事务部长发起了一项新活动,以促进药店和非药店零售环境中对乙酰氨基酚的安全销售。发起这项活动的目的是向这些场所的员工提供新的信息。该计划还旨在提高爱尔兰药店和非药店零售员工对与对乙酰氨基酚有关的故意药物过量服用的认识。
- 2022 年 4 月,IOL Chemicals & Pharmaceuticals Ltd 开始商业化生产“扑热息痛”,装机容量为 1800 吨/年,并向后整合对氨基苯酚 (PAP)。该公司在现有的 4 号装置中生产扑热息痛,该装置已改造为多产品设施,耗资约 120 万美元(近 100 万印度卢比)。另一方面,PAP 正在 9 号装置的一部分中生产。该公司将继续根据市场情况使用 4 号装置和 9 号装置生产其他产品。
- 2022 年 3 月,Paraveganio 成为全球首个获得素食协会批准的素食商标注册的药品。扑热息痛片通常含有硬脂酸镁,可作为流量调节剂。它是一种可能来自动物的硬脂酸和镁盐。Axunio 的 Paraveganio 含有完全来自蔬菜的硬脂酸镁。
- 2021 年 7 月,Hyloris Pharmaceuticals SA 宣布在德国和奥地利推出 Maxigesic IV。Maxigesic IV 是一种新型、获得专利的非阿片类药物,用于治疗术后疼痛,是 1,000 毫克对乙酰氨基酚和 300 毫克布洛芬输液溶液的独特组合。Hyloris 和 AFT Pharmaceuticals(Hyloris 的合作伙伴)拥有多家分销合作伙伴,在当地具有强大的影响力,这有助于他们在全球范围内推广该产品。
竞争格局和重点公司:
Mallinckrodt Pharmaceuticals、GSK plc、Teva Pharmaceutical Industries Ltd.、Sun Pharmaceuticals、Sanofi、Micro Labs Limited、Cipla Inc.、B. Braun Medical Inc.、Dr. Reddy's Laboratories Ltd 和 Fresenius Kabi 是扑热息痛市场报告中介绍的知名企业。此外,在研究过程中还研究和分析了其他几家企业,以全面了解市场及其生态系统。
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
- Medical Devices Market
- Fill Finish Manufacturing Market
- UV Curing System Market
- Transdermal Drug Delivery System Market
- Lyophilization Services for Biopharmaceuticals Market
- Authentication and Brand Protection Market
- Personality Assessment Solution Market
- Playout Solutions Market
- Antibiotics Market
- Latent TB Detection Market
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Based on indication, the market is segmented into fever, cold and cough, mild and moderate pain, and others. The fever segment held the largest market share in 2022. The mild and moderate segment is anticipated to register the highest CAGR from 2022 to 2030.
Based on distribution channel, the paracetamol market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. In 2022, the retail pharmacies segment held the largest market share. It is anticipated to register the highest CAGR during 2022–2030.
The paracetamol market was valued at US$ 9,993.29 million in 2022.
The high prevalence of pain and fever conditions, and rising consumer preference for over-the-counter (OTC) medications are the key factors driving the paracetamol market growth.
Paracetamol is an over the counter non-opioid analgesic and antipyretic medication. It is widely used to treat fever and mild-to-moderate pain. Paracetamol is sold in various forms, including tablets, capsules, soluble powders, and liquids. A few of the common brands of paracetamol include Calpol, Disprol, Hedex, Medinol, and Panadol.
The paracetamol market majorly consists of the players, including Mallinckrodt Pharmaceuticals; GSK plc; Teva Pharmaceutical Industries Ltd.; Sun Pharmaceuticals; Sanofi; Micro Labs Limited; Cipla Inc.; B. Braun Medical Inc.; Dr. Reddy’s Laboratories Ltd; and Fresenius Kabi.
The paracetamol market is expected to be valued at US$ 14,254.44 million in 2030.
Based on dosage form, the paracetamol market is segmented into tablets, capsules, and others. The tablets segment accounted for the largest market share in 2022. It is estimated to register the highest CAGR during 2022–2030.
Based on the route of administration, the paracetamol market is bifurcated into enteral and parenteral. In 2022, the enteral segment held a larger market share, and the same segment is anticipated to register a higher CAGR during 2022–2030.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Paracetamol Market
- Mallinckrodt Pharmaceuticals
- GSK plc
- Teva Pharmaceutical Industries Ltd.
- Sun Pharmaceuticals
- Sanofi
- Micro Labs Limited
- Cipla Inc
- B. Braun Medical Inc.
- Dr. Reddy’s Laboratories Ltd
- Fresenius Kabi
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.